cilobradine
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2003 (NCT02264002)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
COc1ccc(CCN2CCC[C@H](CN3CCc4cc(OC)c(OC)cc4CC3=O)C2)cc1OC- Mol. weight
- 482.62 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1436376 ↗
- ChEMBLCHEMBL2105984 ↗
Also known as
- cilobradine
- cilobradine
- cilobradine
- dk-ah 269 cl
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02264028 | Phase 1 | Mar 1, 2004 | Boehringer Ingelheim |
| NCT02264015 | Phase 1 | Jan 1, 2004 | Boehringer Ingelheim |
| NCT02264041 | Phase 1 | Jan 1, 2004 | Boehringer Ingelheim |
| NCT02264002 | Phase 1 | Feb 1, 2003 | Boehringer Ingelheim |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 4 | 4 | 1 | 2003 |
1 organizations
Page 1 / 1